|
|
||||||||
Articles |
1
"G. Fornaini" Institute of Biological Chemistry, University of Urbino, 2-61029 Urbino, Italy.
2
Nephrology and Dialysis Unit, "R. Silvestrini"
Hospital, 06100 Perugia, Italy.
3
Department of Molecular and Cellular Biology, University
of Perugia, 06100 Perugia, Italy.
a Address correspondence to this author at: Istituto di Chimica Biologica "G. Fornaini", Via Saffi, 2-61029 Urbino (Ps), Italy. Fax 39-722-320188; e-mail galli{at}uniurb.it
Background: Overexpression of glutathione S-transferase (GST; EC 2.5.1.18) has been documented in the erythrocytes of patients with chronic renal failure, and this event may well be of relevance from a clinical standpoint. In fact, it could serve as a marker of uremic toxicity overall, which can contribute to impair the function and survival of the erythrocytes. However, the biochemical details of this phenomenon are poorly understood.
Methods: In this study, we characterized the expression of GST in erythrocytes of 118 uremic patients under different clinical conditions. The mechanisms responsible for the regulation of protein expression and enzyme activity were investigated in light of different dialysis approaches, oxidative stress, uremic toxins, erythrocyte age, and erythropoietin (EPO) supplementation.
Results: Mean GST activity in uremic patients was highly overexpressed with respect to controls, and this phenomenon was exclusively attributable to an increased expression of GST. Overexpression of GST did not appear to be dependent on oxidative stress and was not influenced by vitamin E supplementation. In the same manner, both erythrocyte age and EPO supplementation apparently did not interfere with the GST concentrations, which were the same in controls and patients. Preliminary experiments suggested that high-molecular weight or protein-bound toxins could play some role in the overexpression of GST.
Conclusions: GST expression may be a useful marker for the individual accumulation of uremic toxins as well as of the efficiency of new dialysis strategies in removing them.
The following articles in journals at HighWire Press have cited this article:
![]() |
F. Santangelo, V. Witko-Sarsat, T. Drueke, and B. Descamps-Latscha Restoring glutathione as a therapeutic strategy in chronic kidney disease Nephrol. Dial. Transplant., August 1, 2004; 19(8): 1951 - 1955. [Full Text] [PDF] |
||||
![]() |
A. Floridi, F. Antolini, F. Galli, R. M. Fagugli, E. Floridi, and U. Buoncristiani Daily haemodialysis improves indices of protein glycation Nephrol. Dial. Transplant., May 1, 2002; 17(5): 871 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Klemm, C. Voigt, M. Friedrich, R. Funfstuck, H. Sperschneider, E.-G. Jager, and G. Stein Determination of erythrocyte antioxidant capacity in haemodialysis patients using electron paramagnetic resonance Nephrol. Dial. Transplant., November 1, 2001; 16(11): 2166 - 2171. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |